NIAID-Led Study Indicates SARS-CoV-2 Specific CD8+T Cell Responses Generally Effective Against Variants But More Study Needed
The National Institute of Allergy and Infectious Diseases (NIAID) recently announced promising results from a small but important study involving 30 recovered COVID-19 patients infected…